These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33293607)

  • 1. In vitro synergy of isavuconazole in combination with colistin against Candida auris.
    Schwarz P; Bidaud AL; Dannaoui E
    Sci Rep; 2020 Dec; 10(1):21448. PubMed ID: 33293607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin and Isavuconazole Interact Synergistically In Vitro against
    Schwarz P; Djenontin E; Dannaoui E
    Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32967270
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Schwarz P; Nikolskiy I; Bidaud AL; Sommer F; Bange G; Dannaoui E
    Front Cell Infect Microbiol; 2022; 12():892893. PubMed ID: 35573795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds.
    Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
    J Clin Microbiol; 2013 Aug; 51(8):2608-16. PubMed ID: 23740727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin interacts synergistically with echinocandins against Candida auris.
    Bidaud AL; Djenontin E; Botterel F; Chowdhary A; Dannaoui E
    Int J Antimicrob Agents; 2020 Mar; 55(3):105901. PubMed ID: 31954831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combination therapy with isavuconazole against Candida spp.
    Katragkou A; McCarthy M; Meletiadis J; Hussain K; Moradi PW; Strauss GE; Myint KL; Zaw MH; Kovanda LL; Petraitiene R; Roilides E; Walsh TJ; Petraitis V
    Med Mycol; 2017 Nov; 55(8):859-868. PubMed ID: 28204571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
    Nagy F; Tóth Z; Nyikos F; Forgács L; Jakab Á; Borman AM; Majoros L; Kovács R
    Med Mycol; 2021 Oct; 59(10):1015-1023. PubMed ID: 34021571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species.
    Trovato L; Scalia G; Palermo CI; Costanzo CM; Oliveri S
    Med Mycol; 2019 Jun; 57(4):429-433. PubMed ID: 30124992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect.
    Marcos-Zambrano LJ; Gómez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
    Clin Microbiol Infect; 2018 Dec; 24(12):1343.e1-1343.e4. PubMed ID: 30025834
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Broutin A; Bigot J; Senghor Y; Moreno-Sabater A; Guitard J; Hennequin C
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Seifert H; Aurbach U; Stefanik D; Cornely O
    Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Raffetin A; Courbin V; Jullien V; Dannaoui E
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038263
    [No Abstract]   [Full Text] [Related]  

  • 14. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data.
    Ruiz-Gaitán AC; Cantón E; Fernández-Rivero ME; Ramírez P; Pemán J
    Int J Antimicrob Agents; 2019 May; 53(5):541-546. PubMed ID: 30769198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
    Król J; Nawrot U; Bartoszewicz M
    J Mycol Med; 2018 Jun; 28(2):327-331. PubMed ID: 29605543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of isavuconazole against clinically isolated yeasts from Chile.
    Álvarez Duarte E; Salas V
    Braz J Microbiol; 2020 Dec; 51(4):1801-1805. PubMed ID: 32638272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.
    Pfaller MA; Messer SA; Deshpande LM; Rhomberg PR; Utt EA; Castanheira M
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33431416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
    Diekema DJ; Messer SA; Hollis RJ; Boyken LB; Tendolkar S; Kroeger J; Pfaller MA
    J Clin Microbiol; 2007 Jun; 45(6):1974-7. PubMed ID: 17301284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.
    Arendrup MC; Verweij P; Nielsen HV
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.